-
- 抗原
- Clenbuterol
- 适用
- 请咨询
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- 非结合性
-
应用范围
- ELISA, Flow Cytometry (FACS)
- 交叉反应 (详细)
- Clenbuterol
- 纯化方法
- Purified by Protein A.
- 免疫原
- Clenbuterol conjugated to KLH
- 亚型
- IgG
-
-
- 应用备注
- ELISA 1:500-1000
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 μg/μL
- 缓冲液
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 储存条件
- 4 °C,-20 °C
- 储存方法
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- 有效期
- 12 months
-
-
Spectral surface plasmon resonance imaging for the detection of clenbuterol via three-dimensional immobilization of bioprobes." in: Analytical biochemistry, Vol. 475, pp. 40-3, (2015) (PubMed).
: "Clenbuterol Assay by Spectral Imaging Surface Plasmon Resonance Biosensor System." in: Applied biochemistry and biotechnology, Vol. 177, Issue 6, pp. 1327-37, (2015) (PubMed).
: "
-
Spectral surface plasmon resonance imaging for the detection of clenbuterol via three-dimensional immobilization of bioprobes." in: Analytical biochemistry, Vol. 475, pp. 40-3, (2015) (PubMed).
-
- 抗原
- Clenbuterol
- 物质类
- Chemical
- 背景
-
Synonyms: 1 4 amino 3 5 dichloro phenyl 2 tert butylaminoethanol, Spiropent, Clenbuterol.
Background: Clenbuterol belongs to the group of agonists. In livestock production clenbuterol improves the meat/fat ratio in fattened animals or accelerate the growth. Up to now agonists have not been authorized as adjuvants for fattening. In addition to its lipolytic and anabolic effect, clenbuterol has a relaxing effect on non-striated musculature on which is based its therapeutic use as an antiasthmatic and a tocolytic agent. Clenbuterol is a long acting beta 2 adrenergic agonist. Like other beta 2 agonists, clenbuterol is believed to act by stimulating production of cyclic AMP through the activation of adenyl cyclase. By definition, Beta 2 agonists have more smooth muscle relaxation activity (bronchial, vascular and uterine smooth muscle) versus its cardiac effects (Beta 1).
-